Estrus
Estrus Synchronization
Insemination, Artificial
Progesterone
Cattle
Pregnancy
Melengestrol Acetate
Progesterone Congeners
Estrous Cycle
Diestrus
Synchronization of estrus in beef cattle with norgestomet and estradiol valerate. (1/51)
Fifty-six cows received a norgestomet implant and an injection of norgestomet and estradiol valerate; half (n = 28) received 500 IU equine chorionic gonadotrophin (eCG) at implant removal, 9 d later. A third group (n = 25) received 2 doses of cloprostenol (500 micrograms) 11 d apart. Estrous rate was higher (P < 0.05) for cows given norgestomet and estradiol plus 500 IU eCG (75.0%) than for those receiving cloprostenol (44.0%); for those receiving norgestomet and estradiol alone, it was intermediate (67.8%). Pregnancy rates to artificial insemination (after estrus or timed) were higher (P < 0.05) for cows given norgestomet and estradiol than for those given cloprostenol (23 of 28, 82.1% vs 13 of 25, 52.0%), and intermediate (67.8%) for those given norgestomet and estradiol plus eCG. In a second experiment, for heifers treated with norgestomet and estradiol plus eCG (n = 15) or with 2 doses of cloprostenol (n = 16), estrous rates were 66.7% vs 56.2% (P > 0.5), ovulation rates were 100.0% vs 81.2% (P = 0.08), intervals from implant removal or cloprostenol treatment to estrus were 48.0 +/- 4.4 hours vs 61.3 +/- 7.0 hours (P = 0.12) and to ovulation were 70.4 +/- 4.4 hours vs 93.2 +/- 7.5 hours (P < 0.01), respectively; pregnancy rates were 41.7 and 35.7%, respectively (P > 0.5). Norgestomet and estradiol were as good as (heifers) or superior to (cows) a 2-dose cloprostenol regimen. In cows given norgestomet and estradiol, injecting eCG at implant removal did not significantly improve estrous or pregnancy rates. (+info)Electronic monitoring of mounting behavior in beef cattle on pasture. (2/51)
An automated heatmount detection system was employed to detect estrus for artificial insemination in 57 beef cows. First service conception rate was 84.2% and the pregnancy rate was 89.5% for a 42-day breeding season. Duration of estrus was 9.6 h, sx = 0.5 h and mounting activity was lowest during the dark part of the day. (+info)The importance of seminal plasma on the fertility of subsequent artificial inseminations in swine. (3/51)
Yorkshire x Landrace sows and gilts were used in a 3x2 factorial arrangement of treatments to determine the effect of uterine inflammation induced by either killed spermatozoa (KS) or bacterial lipopolysaccharide (LPS) on the fertility of a subsequent, optimally timed AI. Estrus was detected with a mature boar twice daily. Twelve hours after the first detection of estrus, females received intrauterine infusions of an inflammatory stimulus consisting of a 100-mL dose of extender containing 3x10(9) KS (n = 40), 20 microg of LPS (n = 40; positive control) or extender alone (n = 40; negative control). An insemination was performed 12 to 18 h later with 3x10(9) motile spermatozoa (i.e., fertile AI) suspended in either 100 mL of seminal plasma (SP; n = 60) or extender replenished with of estrogens (5 microg of estradiol-17beta, 4.5 microg of estrone sulfate, and 2 microg of estrone; n= 60). Transcutaneous ultrasound was performed at the time of fertile AI and again 24 h later to detect the presence or absence of preovulatory follicles. A fertile AI performed within 24 h before ovulation was considered optimal. Conception (CR) and farrowing rates (FR) were greater in females that received a fertile AI diluted with SP compared with extender (P<.01), and there was a significant (P<.05) treatment x fertile AI dilution medium interaction for both CR and FR. Females that received a fertile AI 12 h after infusion of extender had similar CR and FR regardless of fertile AI dilution medium. After inducing an inflammatory response with either KS or LPS, CR and FR were higher in females that received a fertile AI diluted with SP compared with fertile AI dilution with extender (P<.05). The effects of treatment and AI dilution media and their interactions were not significant for litter size in females that farrowed. These results show that the fertility of a subsequent AI can be impaired when semen is deposited into an inflamed environment created by an earlier AI, and this impairment was offset by inclusion of SP in the subsequent insemination. (+info)Effects of boar contact and housing conditions on estrus expression in weaned sows. (4/51)
Our objective was to study the effects of housing conditions and the amount of boar contact in a protocol for estrus detection on estrus detection rate, timing of onset of estrus, duration of estrus, and timing of ovulation. After weaning, 130 multiparous sows were assigned to three treatments: HI, in which 52 sows were housed individually in crates and received a high amount of boar contact during estrus detection; HG, in which 52 sows were housed in groups and received a high amount of boar contact; and NI, in which 26 sows were housed individually in crates and received a normal amount of boar contact. Estrus detection was performed every 8 h. For each treatment, the standing response to three levels of stimuli was recorded: a back pressure test (BPT) by a man (man-estrus), presence of a teaser boar (spontaneous-estrus), and BPT in the presence of a teaser boar (boar-estrus). In addition, for HI and HG, the standing response to a fourth level of stimuli was recorded: BPT in a detection-mating area, surrounded by four boar pens (DMA-estrus). To detect ovulation, ultrasonography was performed every 4 h during estrus. Of 117 sows that ovulated, 46% showed man-estrus, 56% spontaneous-estrus, 90% boar-estrus, and 97% DMA-estrus. Mean onset of man-estrus was 107 h (SD 26) after weaning, of spontaneous-estrus was 106 h (SD 22) after weaning, of boar-estrus was 99 h (SD 21) after weaning, and of DMA-estrus was 93 h (SD 22) after weaning. Duration of man-estrus was 22 h (SD 14), of spontaneous-estrus was 29 h (SD 16), of boar-estrus was 42 h (SD 20), and of DMA-estrus was 55 h (SD 18). The high amount of boar contact reduced the number of sows showing man-estrus (P < .05; 41% for HG and HI vs 68% for NI) and reduced duration of boar-estrus (P < .05; 43 h for HG and HI vs 52 h for NI). Duration of DMA-estrus for HG and HI was similar to duration of boar-estrus for NI. Onset of estrus and timing of ovulation were not affected by amount of boar contact. Group housing did not affect detection rate and duration of estrus, but it did postpone average onset of estrus by 10 h, paralleled by a postponement of ovulation. In conclusion, estrus expression is similar at the highest level of stimuli in different protocols for estrus detection. Including higher levels of stimuli in a protocol reduces estrus expression at lower levels of stimuli. This reduction indicates adaptation of sows to a given protocol for estrus detection. Group housing can delay ovulation and related behavioral estrus. (+info)The effect of time of artificial insemination on fertilization status and embryo quality in superovulated cows. (5/51)
Thirty nonlactating Holstein cows were superovulated to determine the effect of artificial insemination time on fertilization status and embryo quality. During the luteal phase of the estrous cycle, cows were administered 38 mg FSH-P in a 4-d descending dose regimen. Luteolysis was induced with two injections of prostaglandin on the last day of FSH-P treatment. All cows were continuously monitored for behavioral estrus using the HeatWatch estrus detection system. All cows were inseminated once with one .5-mL straw (50 x 10(6) sperm) at either 0 (n = 10), 12 (n = 10), or 24 h (n = 10) after the first standing event. The elapsed time (mean +/- SD) from the first prostaglandin dose to the first standing event was 39.4 h +/- 7.7 h. The (mean +/- SD) duration of behavioral estrus was 13.2 h +/- 4.1 h. The (mean +/- SD) number of standing events was 27 +/- 17. Five hundred twenty-nine embryos and ova were recovered nonsurgically 6 d after insemination. Fertilization rates were 29 (0 h), 60 (12 h), and 81% (24 h) (P < .01). Percentages of excellent and good, fair and poor, and degenerate embryos were not different (P > .05). Percentages of embryos with accessory sperm were 5 (0 h), 8 (12 h), and 41 (24 h) and differed between the 0 and 24 h and the 12 and 24 h inseminations (P < .01). Artificial insemination of superovulated, nonlactating Holstein cattle 24 h after onset of estrus increased fertilization rate and percentage of embryos with accessory sperm compared with insemination at 0 or 12 h after onset of estrus. Embryo quality was not affected by time of insemination. (+info)Effects of postweaning dietary energy source on reproductive traits in primiparous sows. (6/51)
An experiment was conducted to study the effects of major dietary energy source fed from weaning to ovulation or from ovulation to d 35 of pregnancy on reproductive traits in primiparous sows. Dietary energy sources were used to manipulate the plasma insulin concentration. One hundred thirteen sows were used in a split-plot design. From weaning to ovulation sows were fed at two times maintenance either a diet with tallow (Fat) or maize starch plus dextrose (Starch) as the major energy source. From ovulation onward, sows within each dietary group were alternately reassigned to either the Fat or the Starch diet and were fed at 1.25 times maintenance. Estrus detection was performed three times a day from d 3 to 9 after weaning and sows were inseminated each day of standing estrus. On d 35 of pregnancy, the sows were slaughtered and their reproductive tracts were removed. Plasma insulin concentration was higher in sows fed the Starch-rich diet than in sows fed the Fat-rich diet on d 4 after weaning (1.30 vs 0.97 ng/mL, P = 0.08) and on d 32 of pregnancy (1.20 vs 0.51 ng/mL, P < 0.001). Plasma glucose and IGF-I concentration on d 4 after weaning and d 32 of pregnancy did not differ between sows on the two dietary energy sources. The percentage of sows exhibiting estrus within 9 d after weaning was 52 and 67% for the Fat and Starch diet before ovulation, respectively (P = 0.11), whereas the weaning-to-estrus interval was 134 vs 123 h, respectively (P = 0.12). Survival analysis showed that sows fed the Fat-rich diet had a 1.6 times higher risk to remain anestrous until d 9 after weaning than sows fed the Starch-rich diet (P = 0.04). No effect of dietary energy source, either before or after ovulation, on uterine, placental, or embryonal development on d 35 of pregnancy was found. It can be concluded that the dietary energy source provided after weaning can affect the risk of sows to remain anestrous but does not affect uterine, placental, or embryonic traits. (+info)Administration of p.g. 600 to sows at weaning and the time of ovulation as determined by transrectal ultrasound. (7/51)
This study determined whether the interval from estrus to ovulation was altered by giving P.G. 600 to sows at weaning. Mixed-parity sows received P.G. 600 i.m. (n = 72) or no treatment (n = 65) at weaning (d 0). Beginning on d 0, sows were observed for estrus twice daily. At the onset of estrus and thereafter, ultrasound was performed twice daily to determine the average size of the largest follicles and time of ovulation. Weaning age (20.1+/-0.4 d) did not differ (P > 0.10) between treatments. More P.G. 600 sows expressed estrus within 8 d (P < 0.01) than controls (94.4% vs 78.4%, respectively). Parity was associated with expression of estrus (P < 0.02), with 78% of first-parity and 93% of later-parity sows exhibiting estrus. However, no treatment x parity effect was observed (P > 0.10). The interval from weaning to estrus was reduced (P < 0.0001) by P.G. 600 compared with controls (3.8+/-0.1 d vs 4.9+/-0.1 d). Follicle size at estrus was not affected by treatment (P > 0.10). The percentage of sows that ovulated did not differ (P > 0.10) for P.G. 600 and control sows (90.3% vs 81.5%, respectively). Time of ovulation after estrus was not affected by treatment and averaged 44.8 h. However, univariate analysis indicated that the interval from weaning to estrus influenced the interval from estrus to ovulation (r = 0.43, P < 0.0001). Further, multivariate analysis showed an effect of treatment on the intervals from weaning to estrus, weaning to ovulation (P < 0.0001), and estrus to ovulation (P < 0.04). Within 4 d after weaning, 81% of the P.G. 600 sows had expressed estrus compared with 33% of controls. However, this trend reversed for ovulation, with only 35% of P.G. 600 sows ovulating by 36 h after estrus compared with 40% of controls. The estrus-to-ovulation interval was also longer for control and P.G. 600 sows expressing estrus < or = 3 d of weaning (45 h and 58 h, respectively) than for sows expressing estrus after 5 d (39 h and 32 h, respectively). Farrowing rate and litter size were not influenced by treatment. However, the interval from last insemination to ovulation (P < 0.02) indicated that more sows farrowed (80%) when the last insemination occurred at < or = 23 to > or = 0 h before ovulation compared with insemination > or = 24 h before ovulation (55%). In summary, P.G. 600 enhanced the expression of estrus and ovulation in weaned sows but, breeding protocols may need to be optimized for time of ovulation based on the interval from weaning to estrus. (+info)Hormonal characterization of the reproductive cycle and pregnancy in the female Mohor gazelle (Gazella dama mhorr). (8/51)
The oestrous cycles of seven captive Mohor Gazelles (Gazella dama mhorr) were investigated. Hormone profiles obtained from faecal samples collected each day from cyclic females indicated that the mean duration of the oestrous cycle was 18.62 +/- 0.26 days (range 16-22 days; n = 37 oestrous cycles). No inter-individual differences in the concentration of faecal progestagen metabolites excreted were observed, but mean faecal oestrogen excretion during both the luteal and inter-luteal phases of the oestrous cycle varied among females (P < 0.001 and P = 0.070, respectively). Oestrous cycles were synchronized using controlled internal drug release (CIDR) devices, before natural mating with an intact male. Concentrations of faecal progestagen metabolites remained approximately constant for the first 10 weeks of gestation (mean +/- SEM = 4048 +/- 407 ng g(-1) faeces), before increasing to a mean of 23 556 +/- 1176 ng g(-1) faeces. Two of seven female gazelles conceived immediately after removal of the CIDR device, a similar proportion to that conceived at the postpartum oestrus under natural conditions. Life history data for these individuals indicated that the mean time to conception in female gazelles is positively correlated with peak values in the ratio of excreted oestrogen : progestagen during the inter-luteal period of their oestrous cycles (R(2) = 0.58; P < 0.05). This finding indicates that interactions between steroid production and metabolism may influence the likelihood of conception occurring in this species. (+info)Estrus detection in veterinary medicine refers to the process of identifying when a female animal is in heat or estrus, which is the period of time when she is fertile and receptive to mating. This is an important aspect of managing breeding programs for livestock and other animals.
Detection of estrus can be done through various methods, including:
1. Observing behavioral changes: Female animals in heat may show signs of increased interest in males, becoming more vocal or restless, and may adopt a mating stance.
2. Physical examination: A veterinarian may perform a physical exam to check for signs of estrus, such as swelling or reddening of the vulva.
3. Hormonal assays: Blood or vaginal fluid samples can be tested for hormone levels, such as estradiol and progesterone, to determine if an animal is in heat.
4. Use of teaser animals: Intact males can be used to stimulate a response in females, indicating that they are in estrus.
Accurate detection of estrus is critical for successful breeding and management of animal reproduction.
Estrus is a term used in veterinary medicine to describe the physiological and behavioral state of female mammals that are ready to mate and conceive. It refers to the period of time when the female's reproductive system is most receptive to fertilization.
During estrus, the female's ovaries release one or more mature eggs (ovulation) into the fallopian tubes, where they can be fertilized by sperm from a male. This phase of the estrous cycle is often accompanied by changes in behavior and physical appearance, such as increased vocalization, restlessness, and swelling of the genital area.
The duration and frequency of estrus vary widely among different species of mammals. In some animals, such as dogs and cats, estrus occurs regularly at intervals of several weeks or months, while in others, such as cows and mares, it may only occur once or twice a year.
It's important to note that the term "estrus" is not used to describe human reproductive physiology. In humans, the equivalent phase of the menstrual cycle is called ovulation.
Estrus synchronization is a veterinary medical procedure used in the management of domestic animals, such as cattle and sheep. It is a process of coordinating the estrous cycles of animals so that they can be bred at the same time or have their fertility treatments performed simultaneously. This is achieved through the use of various hormonal therapies, including progestins, prostaglandins, and gonadotropin-releasing hormones (GnRH).
The goal of estrus synchronization is to improve reproductive efficiency in animal production systems by ensuring that a larger number of animals become pregnant during a shorter breeding season. This can lead to more uniform calf or lamb crops, reduced labor and management costs, and increased profitability for farmers and ranchers.
Estrus synchronization is a complex process that requires careful planning and implementation, as well as ongoing monitoring and evaluation of the animals' reproductive performance. It is typically performed under the guidance of a veterinarian or animal reproduction specialist.
Artificial insemination (AI) is a medical procedure that involves the introduction of sperm into a female's cervix or uterus for the purpose of achieving pregnancy. This procedure can be performed using sperm from a partner or a donor. It is often used when there are issues with male fertility, such as low sperm count or poor sperm motility, or in cases where natural conception is not possible due to various medical reasons.
There are two types of artificial insemination: intracervical insemination (ICI) and intrauterine insemination (IUI). ICI involves placing the sperm directly into the cervix, while IUI involves placing the sperm directly into the uterus using a catheter. The choice of procedure depends on various factors, including the cause of infertility and the preferences of the individuals involved.
Artificial insemination is a relatively simple and low-risk procedure that can be performed in a doctor's office or clinic. It may be combined with fertility drugs to increase the chances of pregnancy. The success rate of artificial insemination varies depending on several factors, including the age and fertility of the individuals involved, the cause of infertility, and the type of procedure used.
Progesterone is a steroid hormone that is primarily produced in the ovaries during the menstrual cycle and in pregnancy. It plays an essential role in preparing the uterus for implantation of a fertilized egg and maintaining the early stages of pregnancy. Progesterone works to thicken the lining of the uterus, creating a nurturing environment for the developing embryo.
During the menstrual cycle, progesterone is produced by the corpus luteum, a temporary structure formed in the ovary after an egg has been released from a follicle during ovulation. If pregnancy does not occur, the levels of progesterone will decrease, leading to the shedding of the uterine lining and menstruation.
In addition to its reproductive functions, progesterone also has various other effects on the body, such as helping to regulate the immune system, supporting bone health, and potentially influencing mood and cognition. Progesterone can be administered medically in the form of oral pills, intramuscular injections, or vaginal suppositories for various purposes, including hormone replacement therapy, contraception, and managing certain gynecological conditions.
"Cattle" is a term used in the agricultural and veterinary fields to refer to domesticated animals of the genus *Bos*, primarily *Bos taurus* (European cattle) and *Bos indicus* (Zebu). These animals are often raised for meat, milk, leather, and labor. They are also known as bovines or cows (for females), bulls (intact males), and steers/bullocks (castrated males). However, in a strict medical definition, "cattle" does not apply to humans or other animals.
Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.
Melengestrol Acetate (MGA) is a synthetic progestin, which is a type of steroid hormone. It is used primarily as a growth promoter in the livestock industry to increase weight gain and feed efficiency in beef cattle. MGA works by suppressing the animal's natural hormonal balance, particularly the levels of estrogen and testosterone, which leads to changes in metabolism and behavior that promote weight gain.
It is not approved for use in humans in many countries, including the United States, due to concerns about potential health risks associated with its long-term use, such as reproductive and developmental effects. However, it has been used off-label in some cases to treat certain medical conditions in women, such as endometriosis or abnormal uterine bleeding, under the close supervision of a healthcare provider.
Ovulation is the medical term for the release of a mature egg from an ovary during a woman's menstrual cycle. The released egg travels through the fallopian tube where it may be fertilized by sperm if sexual intercourse has occurred recently. If the egg is not fertilized, it will break down and leave the body along with the uterine lining during menstruation. Ovulation typically occurs around day 14 of a 28-day menstrual cycle, but the timing can vary widely from woman to woman and even from cycle to cycle in the same woman.
During ovulation, there are several physical changes that may occur in a woman's body, such as an increase in basal body temperature, changes in cervical mucus, and mild cramping or discomfort on one side of the lower abdomen (known as mittelschmerz). These symptoms can be used to help predict ovulation and improve the chances of conception.
It's worth noting that some medical conditions, such as polycystic ovary syndrome (PCOS) or premature ovarian failure, may affect ovulation and make it difficult for a woman to become pregnant. In these cases, medical intervention may be necessary to help promote ovulation and increase the chances of conception.
Progesterone congeners refer to synthetic or naturally occurring compounds that are structurally similar to progesterone, a steroid hormone involved in the menstrual cycle, pregnancy, and embryogenesis. These compounds have similar chemical structures to progesterone and may exhibit similar physiological activities, although they can also have unique properties and uses. Examples of progesterone congeners include various synthetic progestins used in hormonal contraceptives and other medical treatments.
The estrous cycle is the reproductive cycle in certain mammals, characterized by regular changes in the reproductive tract and behavior, which are regulated by hormonal fluctuations. It is most commonly observed in non-primate mammals such as dogs, cats, cows, pigs, and horses.
The estrous cycle consists of several stages:
1. Proestrus: This stage lasts for a few days and is characterized by the development of follicles in the ovaries and an increase in estrogen levels. During this time, the female may show signs of sexual receptivity, but will not allow mating to occur.
2. Estrus: This is the period of sexual receptivity, during which the female allows mating to take place. It typically lasts for a few days and is marked by a surge in luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which triggers ovulation.
3. Metestrus: This stage follows ovulation and is characterized by the formation of a corpus luteum, a structure that produces progesterone to support pregnancy. If fertilization does not occur, the corpus luteum will eventually regress, leading to the next phase.
4. Diestrus: This is the final stage of the estrous cycle and can last for several weeks or months. During this time, the female's reproductive tract returns to its resting state, and she is not sexually receptive. If pregnancy has occurred, the corpus luteum will continue to produce progesterone until the placenta takes over this function later in pregnancy.
It's important to note that the human menstrual cycle is different from the estrous cycle. While both cycles involve hormonal fluctuations and changes in the reproductive tract, the menstrual cycle includes a shedding of the uterine lining (menstruation) if fertilization does not occur, which is not a feature of the estrous cycle.
Diestrus is a stage in the estrous cycle of animals, which is similar to the menstrual cycle in humans. It follows the phase of estrus (or heat), during which the animal is receptive to mating. Diestrus is the period of relative sexual quiescence and hormonal stability between cycles. In this phase, the corpus luteum in the ovary produces progesterone, preparing the uterus for potential pregnancy. If fertilization does not occur, the corpus luteum will degenerate, leading to a drop in progesterone levels and the onset of the next estrous cycle. The duration of diestrus varies among species.
In humans, this phase is analogous to the luteal phase of the menstrual cycle. However, since humans do not exhibit estrous behavior, the term 'diestrus' is typically not used in human reproductive physiology discussions.
Dinoprost is a synthetic form of prostaglandin F2α, which is a naturally occurring hormone-like substance in the body. It is used in veterinary medicine as a uterotonic agent to induce labor and abortion in various animals such as cows and pigs. In human medicine, it may be used off-label for similar purposes, but its use must be under the close supervision of a healthcare provider due to potential side effects and risks.
It is important to note that Dinoprost is not approved by the FDA for use in humans, and its availability may vary depending on the country or region. Always consult with a licensed healthcare professional before using any medication, including Dinoprost.
Estrus (Heat) Detection in Cattle | Page 77 | Mississippi State University Extension Service
Bubaline Theriogenology | IVIS
Estrus Detection Methods in Dairy Animals- Advances and the Prospects: A Review
Dairy cattle - Wikipedia
Artificial Insemination in Swine: Breeding the Female | MU Extension
SciELO - Brazil - Correlation between estrus onset and ovarian parameters in dairy goats Correlation between estrus onset and...
Registration Dossier - ECHA
New Technologies on Show at Dairy Showcase | The Cattle Site
PDF) Effects of attapulgite dietary supplementation on sow performance in two commercial farms in Greece
Volume 99 Issue 1 | Canadian Journal of Animal Science
Winrock International » An Animal Breeder's Dream
A CNN-based methodology for cow heat analysis from endoscopic images | Applied Intelligence
John L. P. Thompson - Google Scholar
Evaluation of the 7 and 7 synch protocol for control of the estrous cycle among beef cows prior to fixed-time artificial...
Heat Detection and Timing of Artificial Insemination
Underlying Disorders of Postpartum Anoestrus and Effectiveness of their Treatments in Crossbred Dairy Cows
Estrotect Patches-Orange (50/pkg) - Bovine Elite
Dairy Research Bulletin - July 2020 - California Dairy Research Foundation
Can a 12 month old bull breed? - Erasingdavid.com
P.G. 600-5D for Animal Use (Canada) - Drugs.com
New mobile health diagnostic for breeding helps meet growing demand for food | The Pig Site
Hormonal Control of Estrus in Cattle - Management and Nutrition - MSD Veterinary Manual